Invasive fungal infections are increasingly recognized as a primary cause of morbidity and mortality, especially in immunocompromised patients. The frequency of nosocomial candidemia has increased 10-fold during the past two decades (3) . Candida albicans, formerly the most important species, is still the one which most often causes disease. However, other species than C. albicans, in particular, Candida glabrata, but also Candida tropicalis, Candida krusei, and Candida parapsilosis, have gained greater significance and must not be overlooked (15, 31) . The prevalence of candidiasis and the increase in Candida being resistant to polyene and azole drugs have made rapid species differentiation mandatory (29, 31) . There has been a less striking, though also substantial, increase in the incidence of invasive aspergillosis (IA) (27) . Invasive aspergillosis is mainly caused by Aspergillus fumigatus, followed by Aspergillus flavus and Aspergillus terreus. Other species, such as Aspergillus nidulans, Aspergillus niger, and Aspergillus ustus, are rarely found in diagnosing IA.
The definite and rapid diagnosis of invasive fungal infections is difficult due to the lack of sensitive test methods. Therefore, efforts to improve diagnosis are ongoing and need to be further intensified. Although proving the presence of infection by histology and culture remains the cornerstone of diagnosis, nonculture-based methods are being developed to allow early detection. Among the most promising approaches are the detection of fungal antigens and PCR (2, 4, 42) . The results of some studies suggest that a combination of the Aspergillus galactomannan enzyme-linked immunosorbent assay (GM-ELISA) and real-time PCR may provide improved diagnosis of invasive aspergillosis (5, 7, 20, 35) . Nevertheless, not only the detection of fungi, but also their identification, which can be obtained only by PCR or culture, is important for the optimal choice of antifungals and duration of therapy. A variety of PCR assays based on the detection of fungal DNA in sterile human body fluids or tissue samples to allow early diagnosis of fungal infections and to improve the survival rate of patients suffering from invasive infections has been described. However, in contrast to the GM-ELISA, none of the developed PCR assays have been standardized, resulting in diverging results. In general, the introduction of real-time PCR technology in the detection of fungal infections has increased the reliability of PCR results compared to results obtained by conventional PCR methods. Real-time PCR sharply decreases the risk of false-positive results due to PCR product carryover during gel electrophoresis with subsequent Southern blot hybridization or enzyme-linked immunoassays to check the specificity of the PCR product. The identification of species via melting curve analysis with species-specific hybridization probes further increases specificity, as one mismatch in the probe binding site would lead to an altered melting temperature (T m ). The fast turnaround time of less than 2 h is another advantage of the real-time PCR technology (4, 13, 14) .
Although infections with Candida and Aspergillus species are the ones most encountered by high-risk patients, there are only a few reports of PCR assays specifically targeting Candida spp. and Aspergillus spp. at the same time (21, 32) . Furthermore, the majority of Aspergillus-specific real-time PCR assays are restricted to the detection of A. fumigatus alone. Therefore, we have decided to design a real-time PCR approach which enables culture-independent screening for Candida and Aspergillus infections within only a few hours. The aim of this study was to develop assays specific for the fungal ITS2 region, allowing the simultaneous detection and differentiation of 11 medically important species of Aspergillus (Aspergillus fumigatus, Aspergillus flavus, Aspergillus nidulans, Aspergillus niger, and Aspergillus terreus) and Candida (Candida albicans, Candida dubliniensis, Candida glabrata, Candida krusei, Candida parapsilosis, and Candida tropicalis) with species-specific biprobes on the LightCycler instrument (Roche Diagnostics GmbH, Mannheim, Germany). Biprobes were chosen as they guarantee high specificity and have not yet been applied to the species differentiation of fungi. Fungal isolates were cultured by standard cultivation methods. Cell suspensions were prepared with 0.9% saline and adjusted to a 3 McFarland standard. For quantification of the Candida and Aspergillus suspensions, 10-fold serial dilutions were plated and CFU were counted. The fungal suspensions were centrifuged, resuspended in 200 l 0.9% NaCl, and incubated with 20 U recombinant Lyticase (Sigma-Aldrich, Austria) at 37°C for 30 min. DNA was extracted with a High Pure PCR template preparation kit (Roche Molecular Biochemicals, Mannheim, Germany) by following the instructions of the manufacturer. DNA was eluted with 100 l elution buffer provided with the kit.
MATERIALS AND METHODS

Fungal
Clinical samples. Samples obtained for routine microbiology diagnostic procedures from patients suspected and not suspected of having fungal infections were retained for evaluation of the PCR assays. Bronchoalveolar lavage (BAL) (n ϭ 19), bronchial secretion (n ϭ 5), and tracheal secretion (n ϭ 2) samples and an EDTA-anticoagulated blood sample (n ϭ 1) from lung transplant recipients and from patients in the intensive care unit were used for further investigations. Tissue samples from the maxillary sinus (n ϭ 4) were obtained from patients with histologically proven fungus balls. Part of the material was cultured using standard cultivation methods. The remaining material (1 to 2 ml) was stored at Ϫ20°C until it was used for DNA extraction.
DNA extraction from 3 ml EDTA-blood sample. A modification of a protocol described by Loeffler et al. (25) was used. For red cell lysis, 3 ml EDTA-blood was mixed with 15 ml lysis buffer (LB; 10 mM Tris [pH 7.6], 5 mM MgCl 2 , 10 mM NaCl), incubated for 15 min on ice, and then centrifuged for 10 min at 3,000 rpm. The pellet was resuspended in 15 ml LB, incubated again for 15 min on ice, and then centrifuged for 10 min at 3,000 rpm. For white cell lysis, the pellet was then resuspended in 1 ml LB containing 200 g/ml protease (QIAGEN, Hilden, Germany), incubated at 65°C for 45 min, and then centrifuged at 13,000 rpm for 10 min. In order to obtain spheroplasts, the pellet was resuspended in 500 l Lyticase solution (50 mM Tris [pH 7.6], 1 mM EDTA [pH 8.0], 0.2% 2-mercaptoethanol) containing 20 U recombinant Lyticase, incubated at 37°C for 30 min, and then centrifuged at 13,000 rpm for 10 min. Finally, DNA was extracted with a High Pure PCR template preparation kit by following the instructions of the manufacturer. DNA was eluted with 100 l elution buffer.
DNA extraction from 200 l cerebrospinal fluid (CSF), BAL, bronchial, or tracheal secretion samples. For concentration of the fungi, 1 to 2 ml of the specimen was centrifuged for 5 min at 13,000 rpm. In order to obtain spheroplasts, the pellet plus 200 l supernatant was incubated with 20 U recombinant Lyticase at 37°C for 30 min. Finally, DNA was extracted with a High Pure PCR template preparation kit by following the instructions of the manufacturer. DNA was eluted with 100 l elution buffer.
DNA extraction from tissue samples. Tissue (0.02 g) was incubated in 200 l elution buffer and 200 l binding buffer from the High Pure PCR template preparation kit with 900 g protease at 55°C until the tissue was completely digested. After inactivation of the protease (95°C for 5 min), the sample was treated with 20 U recombinant Lyticase at 37°C for 30 min to obtain spheroplasts. Finally, DNA was extracted with a High Pure PCR template preparation kit by following the instructions of the manufacturer. DNA was eluted with 100 l elution buffer.
In order to avoid contamination, all steps were performed with aerosol-resistant tips. DNA extraction, preparation of the master mix, and addition of the template were carried out in two separate rooms. For each extraction, a reagent blank was carried out to exclude false-positive PCR results due to contamination.
Aspergillus-and Candida-specific biprobe assays. GenBank was searched for sequences of the ITS2 regions of Candida and Aspergillus species and phylogenetically related fungi. The published sequences were aligned using ClustalW (http://www.ebi.ac.uk/clustalw/), and primers and probes were designed. A BLAST search (http://www.ncbi.nlm.nih.gov/BLAST/) was performed to check the specificity of the DNA sequences of the primers and probes. The sequences of the primers and probes are shown in Table 1 . Primer Asp-F is mainly specific for members of the Hyphomycetes, whereas primer Cand-F is mainly specific for members of the yeasts. Both primers anneal within the ITS2 region. Primer ITS-R anneals to a highly conserved region of the 28S rRNA gene. For the detection and differentiation of the five Aspergillus species and the six Candida species, 11 different species-specific biprobes were designed, allowing species identification by specific melting peaks. Sequence alignments of the corresponding Aspergillus and Candida species are shown in Fig. 1 and 2 , respectively.
To facilitate rapid screening for the presence of Candida or Aspergillus in a sample, the six Candida-specific biprobes or the five Aspergillus-specific biprobes were used together in one reaction mixture. The 20-l real-time PCR mixtures were prepared with 2 l of LightCycler-FastStart DNA master SYBR green I (Roche Molecular Biochemicals, Mannheim, Germany), 4 mM MgCl 2 , primers and probes as shown in Table 1 , and 3 l of DNA extract made up to 20 l with water. PCRs were performed in a LightCycler instrument with preliminary denaturation for 10 min at 95°C, followed by 60 amplification cycles (with a temperature transition rate of 20°C/s) of denaturation at 95°C for 8 s, annealing at 55°C for 10 s, and primer extension at 72°C for 10 s, with a single fluorescence acquisition step at the end of the extension. This was followed by a melting analysis of the probe-PCR product duplex consisting of 95°C for 30 s and then cooling to 35°C for 60 s before the temperature was raised to 98°C at a rate of 0.2°C/s with continuous fluorescence acquisition. A final cooling step was performed at 40°C for 10 s.
Light emission due to SYBR green was monitored in the F1 channel, whereas biprobe-specific melting peaks were analyzed in the F3 channel of the instrument. Samples were considered positive for an Aspergillus or Candida species upon the presence of a biprobe-specific melting peak. In this case, the species was confirmed by repeating the analysis with the appropriate specific biprobe in the reaction mixture. Specific T m values of the biprobes are shown in Table 1 . Melting peaks obtained with the Aspergillus and Candida species-specific biprobes are shown in Fig. 3 and 4 , respectively.
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The detection of galactomannan in the blood sample (patient 26) was performed by means of the Platelia Aspergillus enzyme immunoassay (EIA) kit (Bio-Rad Laboratories Central Europe, Vienna, Austria), according to the manufacturer's instructions.
Evaluation of analytical sensitivity and specificity. In order to evaluate the analytical sensitivity of the assays, dilutions of DNA of the 11 species in the range between 10 5 and 10 Ϫ1 CFU per PCR were used as template DNA. For evaluation of the DNA extraction protocols, 3 ml EDTA-blood, 200 l CSF, and 0.02 g tissue (aorta) of noninfected patients or healthy volunteers were spiked with dilutions of C. albicans and A. fumigatus in the range between 10 4 and 10 0 CFU/ml. DNA was extracted and analyzed. To confirm the absence of PCR inhibitors, one additional reaction mixture containing the DNA extract was spiked with 4 CFU of C. albicans or A. fumigatus to exclude inhibition. The analytical specificity of the assays was evaluated with DNA extracted from Aspergillus, Candida, and all the other fungal isolates described. Furthermore, BLAST analyses of primers and probes were performed.
RESULTS
Specificity of the Aspergillus-specific biprobes and melting temperature values. A BLAST search was performed to check the specificity of the Aspergillus-specific biprobes. Biprobes specific for A. flavus, A. fumigatus, A. nidulans, and A. niger had 100% sequence similarity to each of the respective Aspergillus strains in the database. They further revealed 100% similarity to some other Aspergillus, Emericella, and Neosartorya species, which may lead to cross-reactions ( Table 2 ). The biprobe specific for A. terreus showed mismatches with three A. terreus strains (Fig. 1) . To further prove the specificity, DNA of all fungal isolates mentioned under "Fungal strains and DNA extraction" was tested with each of the Aspergillus species-specific biprobes. As expected, cross-reactivity of biprobe A.nid-S was observed with A. sydowii, A. ustus, and A. versicolor. No cross-reactivity was observed with the other isolates. The T m values of the biprobe-specific melting peaks are shown in Table 1 and Fig. 3 . A. terreus strain CBS 116.46 revealed a biprobe-specific melting peak with a T m value of 57°C instead of 66°C. The PCR product of this strain was sequenced and revealed the same sequence variation as the two strains with accession numbers AJ001333 and AJ001331 found in the database. Occasionally, an indistinct and broad peak at the 52°C T m was observed when the five Aspergillus species-specific biprobes were used together for screening (Table 3) .
Specificity of the Candida-specific biprobes and melting temperature values. A BLAST search was performed to check the specificity of the Candida-specific biprobes. Each biprobe had 100% sequence similarity to the respective Candida strains in the database. None of those revealed 100% similarity to any other sequence (Table 2) . To further prove the specificity, DNA of the fungal isolates described above was tested with each of the Candida species-specific biprobes. Table 1 and Fig.   4 show the T m values of the biprobe-specific melting peaks. One clinical isolate of C. albicans revealed a biprobe-specific peak T m of 55°C instead of 66°C. The PCR product of this strain was sequenced and revealed one mismatch in the biprobe-specific annealing site (Fig. 2) . Furthermore, C.alb-S showed cross-reactivity with C. dubliniensis (T m value of 47°C), C.dubl-S showed cross-reactivity with C. albicans (T m value of 52°C), and C.glab-S showed cross-reactivity with S. cerevisiae (T m value of 50°C). 
DISCUSSION
The detection of noncultivable/nonviable cells and circulating free fungal DNA by PCR has been described as an important tool in the early diagnosis of aspergillosis and candidiasis (4). As a rapid diagnosis would improve the survival rate in high-risk patients, we decided to design a real-time PCR approach which enables screening for Aspergillus and Candida infections within a few hours. To our knowledge, no protocol using biprobes to detect and distinguish either Aspergillus or Candida species exists. So far, real-time PCR with biprobes has been restricted to a few studies for the detection of Helicobacter pylori, Campylobacter spp., Mycobacterium tuberculosis, and coagulase-negative staphylococci and for the detection, but not the differentiation, of seven Candida species (10, 11, 28, 36, 43) . In this study, the application of the biprobe technology facilitated a rapid screening for and simultaneous differentiation of 11 medically important Aspergillus and Candida species in only two individual PCR mixtures and simultaneously in the same LightCycler run. Biprobes are sequencespecific hybridization probes labeled with the fluorophore Cy5, which is excited by SYBR green I when the probe hybridizes to the target sequence. High specificity of the assay is guaranteed by the right peak T m , as a probe-specific melting peak with the appropriate T m can be considered to be a positive result. In both assays, a group-specific and a universal primer were combined with species-specific probes. This enabled a higher degree of specificity than that obtained with genus-specific probes and minimized the risk of false-positive results due to exogenous environmental fungal DNA, such as that of Penicillium, Alternaria, and Saccharomyces species. Nevertheless, one of the drawbacks of the biprobe technology may be the fact that it does not allow for quantification of the pathogen. As a consequence, differentiating between colonization and infection when investigating specimens from sterile body sites may become more difficult. At present, all PCR results of these specimens must be collated with other clinical evidence, such as radiology, culture, histopathology, patient history, and other diagnostic assays.
Our Aspergillus assay includes not only A. fumigatus, but also A. flavus, A. nidulans, A. niger, and A. terreus, which in general extends the diagnostic range of Aspergillus-specific real-time PCR. TaqMan-and HybProbe-based real-time PCR tests for the diagnosis of aspergillosis have so far been targeted to the detection of A. fumigatus only, with the notable exception of an assay described by Costa et al. (7) designed for the detection of A. fumigatus and A. flavus. A PCR-EIA for the detection and differentiation of seven medically important Aspergillus species was designed by de Aguirre et al. (9) . Nevertheless, although aspergillosis is mainly due to A. fumigatus, species such as A. flavus, A. terreus, and others are also of clinical importance. The ability to detect and distinguish between the various clinically relevant Aspergillus species is of great diagnostic value, as certain species vary in their resistance to antifungal therapy and are associated with increased virulence and higher mortality. This is mainly the case for A. terreus and A. nidulans, which are frequently resistant to amphotericin B (22, 23) . Various PCR targets have been evaluated, but the most commonly used are sequence areas within the ribosomal DNA gene complex (4-8, 19, 20, 26, 30, 32, 34, 35, 39) . However, several studies have shown that the ITS1 or ITS2 regions are the most promising targets for refined discrimination between Aspergillus species (9, 17, 33) . Our BLAST analyses and alignments of the ITS region revealed that some Aspergillus species are phylogenetically very closely related and show high sequence identity to other fungi, such as Penicillium and Verticillium. In fact, some species cannot be identified to the species level due to identical ITS2 sequences. For example, Aspergillus phoenicis, Aspergillus awamori, Aspergillus foetidus, and Aspergillus tubigensis are molecular siblings of A. niger; Aspergillus oryzae and Aspergillus parasiticus of A. flavus; and Emericella rugulosa and Emericella quadrilineata of A. nidulans. However, this should not be of major concern, as therapy would not be altered substantially for these species. On the other hand, some intraspecies sequence diversity is found in the ITS2 region. Thus, for each Aspergillus species, probes with a 100% intraspecies sequence similarity had to be designed. BLAST analyses and PCR revealed no strain-to-strain variability in the probe binding regions, except for A. terreus. As expected, the intraspecies sequence diversity and the presence of molecular siblings resulted in some potential for cross-reactivity only with very closely related species, as shown in Table 2 .
As yet, published Candida-specific real-time PCR assays have been based on species-specific TaqMan probes or hybridization probes (8, 16, 26, 37, 38, 43, 44) . Most of these assays facilitated the specific detection of medically important Candida species and were tested on DNA extracted from blood cultures and whole-blood samples. The ability to distinguish between the various clinically relevant Candida species is of eminent importance for guidance on the specific therapy. Although C. krusei is intrinsically resistant to fluconazole and C. glabrata and C. tropicalis may become resistant very quickly during therapy, fluconazole remains the drug of choice to treat invasive candidiasis (41) and the identification of the species is rated as indispensable in critical specimens. For Candida, it is much easier to develop species-specific real-time protocols, since this genus is phylogenetically more diverse than Aspergillus. The Candida-specific assays introduced in the present study were highly specific. Cross-reactions of probes designed for C. albicans, C. dubliniensis, and C. glabrata could easily be detected by a lower (minimum of more than 8°C difference) peak T m . The ITS2 region showed some intraspecies sequence diversity for several Candida species. However, except for the probe specific for C. albicans, no strain-to-strain variability was observed in the other probe binding regions. Our results are in agreement with those of others suggesting that the ITS2 region is a proper target for the differentiation of Candida species (37) .
Both real-time PCR assays proved to be highly sensitive (5 to 10 CFU/ml). For a preliminary clinical evaluation, samples from the respiratory tract and tissue samples were examined by culture and real-time PCR. The combination of a group-specific and a universal primer with five Aspergillus or six Candida species-specific probes in one reaction mixture facilitates rapid screening. However, results showed that the differentiation of species with a peak T m difference of 1°C is difficult. In addition, with clinical samples, the peak T m of hybridization probes can vary slightly. This was observed with patients 6 and 19. Here, the C. dubliniensis-specific biprobe was detected at a peak T m of 63°C instead of 62°C. As a consequence, species confirmation should be performed with the corresponding biprobes whenever the Candida assay reveals a peak T m between 62°C and 66°C. This is true for C. albicans, C. dubliniensis, C. glabrata, and C. tropicalis. Concerning the Aspergillus assay, A. fumigatus and A. nidulans show the same peak T m of probes and should also be confirmed in a second PCR.
In the present study, real-time PCR showed mostly a higher sensitivity than culture. Since different forward primers were used for Aspergillus and Candida, simultaneous occurrence of Aspergillus and Candida could be properly determined in the majority of cases. In some samples, PCR even detected a greater number of different Aspergillus and Candida species than culture. In these cases, patients had received antifungal therapy before sampling, which may be a reason for these discrepancies. Furthermore, whenever C. albicans was detected in addition to the cultured Candida (C. glabrata and C. tropicalis) or Aspergillus (A. fumigatus and A. flavus) species, C. albicans might have been overgrown by the other fungi and therefore missed by culture. On the other hand, culture detected a greater number of different species than real-time PCR in three samples, which may be due to an outcompetition of a species present in lower numbers. The higher sensitivity of the real-time PCR was clearly indicated by the results obtained from the fungus balls, all of them being PCR positive and culture negative. Discrepancies in the results of culture and PCR are well known and have already been observed in previous studies (45) . In addition, culture of the blood sample from patient 26, with histology-proven aspergillosis, was negative, whereas real-time PCR detected A. flavus. In general, blood culture is considered to be an important tool for the detection of systemic infection, but it has been shown to be positive in less than 50% of patients with chronic disseminated candidiasis (12) . Blood cultures of patients suffering from invasive aspergillosis remain negative in almost all cases (18) . Also, the sensitivity of cultures from BAL fluid is low. As has been described by Levy et al. (24) , Aspergillus spp. are isolated in only 50 to 57% of all cases.
However, it has to be considered that the newly developed assays cover the range of the most important, but not every, Aspergillus and Candida species. This is illustrated by a sample for which real-time PCR did not detect C. lusitaniae, since the Candida-specific assay does not include a biprobe for this species. PCR detected C. glabrata instead. A cross-reaction of C. lusitaniae with C. glabrata can be excluded, as primer Cand-F shows 2 mismatches at the 3Ј end with C. lusitaniae, which would most probably prevent the amplification of C. lusitaniae in a clinical sample. Furthermore, the biprobe C.glab-S reveals 10 mismatches with the ITS2 region of C. lusitaniae.
In summary, this is the first real-time PCR assay which allows the simultaneous detection and identification of various Candida and Aspergillus species. The results of the analytical and clinical evaluations show that both assays are highly sensitive and can be used in clinical laboratories as simple screening tests for the most commonly encountered Aspergillus and Candida species. As our results have been quite promising, it is planned to evaluate the clinical impact of these assays in combination with other tests, such as the detection of GM, in a prospective study which will start in the near future.
